COVID-19 SARS-CoV-2 rS nanoparticle vaccine with Matrix-M adjuvant
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for COVID-19 SARS-CoV-2 rS nanoparticle vaccine with Matrix-M adjuvant, covering 2023-04-10 to 2023-04-10. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of the Safety and Immunogenicity of a SARS-CoV-2 rS Nanoparticle Vaccine With/Without Matrix-M Adjuvant [Phase 1, Phase 2]